Skip to main content
Contact Us
Subscribe
E-Edition
93°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Psilocybin Trials For COVID-Related Distress Of Healthcare Professionals Could Validate New Psychotherapy Model
November 30, 2021
Tickers
CYBN
Tags
Health Care
Benzinga
Penny Stocks
From
Benzinga
Cybin To Test Psychedelic-Assisted Psychotherapy For COVID-Related Distress
November 30, 2021
Tickers
CYBN
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Cybin Supports Psychedelic Treatment Clinic Through Grant
November 23, 2021
Tickers
CYBN
Tags
CYBN
Partner Content
Market News
From
Benzinga
NY's Lenox Hill Hospital With Cybin-Awarded Grant Will Provide Psychedelic Therapy To City's Underserved
November 23, 2021
Tickers
CYBN
Tags
Markets
Cannabis
Market News
From
Benzinga
Cybin 'One Step Closer' to Creating Best Therapy for Mental Health
November 19, 2021
Tickers
CYBN
Tags
Partner Content
CYBN
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Tickers
ABCL
ACGL
AIG
AJG
Tags
SIRI
DRNA
MTDR
From
Benzinga
Cybin Reports Q2 Financial Results And Latest News, Including FDA & DEA Research Approvals
November 15, 2021
Tickers
CYBN
Tags
Market News
CYBN
Doug Drysdale
From
Benzinga
Cybin Releases Q2 Financial Results
November 15, 2021
Tickers
CYBN
Tags
News
InvestorBrandNetwork
Earnings
From
Benzinga
Can The Psychedelics Boom Go Bust? A Conversation With Cybin Chief Clinical Officer Dr. Alex Belser
November 14, 2021
Tickers
CYBN
Tags
Market News
Cannabis
CYBN
From
Benzinga
Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the 'Superior Molecule'
November 11, 2021
Tickers
CYBN
Tags
Small Cap
Cannabis
Market News
From
Benzinga
Cybin CEO Presenting at Jefferies London Healthcare Conference
November 11, 2021
Tickers
CYBN
Tags
Benzinga
General
Small Cap
From
Benzinga
Cybin to Release Q2 2021 Results on November 15
November 09, 2021
Tickers
CYBN
Tags
Markets
Market News
Cannabis
From
Benzinga
32 Stocks Moving in Tuesday's Pre-Market Session
November 09, 2021
Tickers
AMRS
APRN
ARVL
ATER
Tags
DDD
Trading Ideas
Pre/Market Outlook
From
Benzinga
64 Biggest Movers From Yesterday
November 09, 2021
Tickers
ALHC
ALIM
ASRT
AURA
Tags
Movers
EHTH
ASRT
From
Benzinga
Cybin Announces Positive Data Showing Effectiveness of Psilocybin To Treat Depression
November 08, 2021
Tickers
CYBN
Tags
Benzinga
Biotech
General
From
Benzinga
Cybin's CYB003 Demonstrates Advantages over Oral Psilocybin for Mental Health
November 08, 2021
Tickers
CYBN
Tags
Benzinga
Partner Content
CYBN
From
Benzinga
Why Cybin Stock Is Down on Monday
November 08, 2021
Tickers
CYBN
Tags
CYBN
Market News
Recent Press Releases
From
Motley Fool
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
November 08, 2021
Tickers
CMPS
CYBN
FLHLF
NMLSF
Tags
psychedelics
TRYPF
Penny Stocks
From
Benzinga
Cybin Gets DEA License To Work With Scheduled Psychedelic Molecules
November 04, 2021
Tickers
CYBN
DEA
Tags
Cannabis
Market News
Markets
From
Benzinga
Cybin Inc. Receives Schedule I Manufacturing License from DEA
November 04, 2021
Tickers
CYBN
Tags
Cannabis
Market News
Markets
From
Benzinga
Cybin Inc. Schedules R&D Briefing to Release Breakthrough Research Findings
November 02, 2021
Tickers
CYBN
Tags
InvestorBrandNetwork
Benzinga
Penny Stocks
From
Benzinga
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
Tickers
AWKNF
CYBN
DELCF
MCURF
Tags
MNMD
AWKNF
Benzinga
From
Benzinga
Cybin: FDA Authorizes Feasibility Study To Measure Ketamine's Effect On Cerebral Cortex
October 27, 2021
Tickers
CYBN
Tags
Market News
Cannabis
Markets
From
Benzinga
Cybin Inc. Announces FDA IND Authorization of Potentially Pivotal Study
October 27, 2021
Tickers
CYBN
Tags
Health Care
Penny Stocks
InvestorBrandNetwork
From
Benzinga
Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent
October 26, 2021
Tickers
AWKNF
CMPS
CYBN
DMTTF
Tags
DMTTF
FTRP
psychedelics
From
Benzinga
These 4 Psychedelic Biotech Stocks Are Leading the Pack
October 26, 2021
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
Market News
CYBN
ATAI
From
Motley Fool
Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma
October 19, 2021
Tickers
CYBN
FTRP
Tags
FTRP
Field Trip Psychedelics
Cybin Corp
From
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
HSTRF
AWKNF
RVVTF
From
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Tickers
AGNPF
ALID
ATAI
AWKNF
Tags
Benzinga
ALID
MNMD
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Tickers
AC
ACA
ACI
ADDYY
Tags
NKE
Benzinga
SBUX
From
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.